# Efficacy and Safety of XT-150 in Osteoarthritis of the Knee

> **NCT04124042** · PHASE2 · COMPLETED · sponsor: **Xalud Therapeutics, Inc.** · enrollment: 289 (actual)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **BIOLOGICAL:** XT-150
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04124042
- **Lead sponsor:** Xalud Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-14
- **Primary completion:** 2022-04-26
- **Final completion:** 2022-04-26
- **Target enrollment:** 289 (ACTUAL)
- **Last updated:** 2025-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04124042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04124042, "Efficacy and Safety of XT-150 in Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04124042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*